The host-vector shuttle and the bottleneck in dengue transmission is a significant aspect with regard to the study of dengue outbreaks. As mosquitoes require 100-1000 times more virus to become infected than human, the transmission of dengue virus from human to mosquito is a vulnerability that may be able to be targeted to improve disease control. In order to capture the heterogeneity in the infectiousness of an infected patient population towards the mosquito pool, we calibrate a population of host-to-vector virus transmission models based on an experimentally quantified infected fraction of a mosquito population. Once the population of models is well-calibrated, we deploy a population of controls that helps to inhibit the human-to-mosquito transmission of the dengue virus indirectly by reducing the viral load in the patient blood. We use an optimal bang-bang control on the administration of the defective virus (transmissible interfering particles, known as TIPs) to symptomatic patients in the course of their febrile period and observe the dynamics in successful reduction of dengue spread.
traditional SIR approach but do not include the recovered (R) compartment, as mosquitoes die naturally before they can recover from dengue virus infection. We construct a population of models (see section 2.3) calibrating the range of the distribution of infectedness on each day. The transmission model utilizes the patient viremia and defective interfering (DI) particle profiles data obtained from our previous model [33] . Here, we construct the patient infectiousness model only.
The model, we adopt, can explain the infected fraction of the mosquito population in terms of the transmission of viremia from the infectious patients. The model has an input of the plasma viral load from infected patient models, as shown below.
Here, S, I V , I D , and I V D are the susceptible and three kinds of infected pools of mature mosquitoes, respectively. The Characterising the variability between individuals from the same species is fundamental in biology. In our setting, every 84 infected individual in a population may not produce similar infectiousness to the similar groups of susceptible, mature 85 mosquitoes. The underlying variability may be manifested by: (1) the patients' physiology and immunological response,
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(2) behaviour of the uptaken virus on interaction with the host cells, (3) mosquito physiology. The first two points are 87 covered when we use a calibrated population of patients' viral load (V (t)) and associated DI particles (D(t)). To capture 88 the variability in patient infectiousness towards mosquitoes, a population of models approach is used for the transmission 89 model. The main purpose of such a study is to decipher how a particular population of patients are different from the 90 others (i.e., infectiousness to mosquitoes at different levels of viral load) and on the clinical realm, compared with the 91 4/14 treated (controlled) population. In a clinical and experimental framework it is difficult to track the variability, so 92 population of mathematical models can overcome this problem even in low sample size. Two patients with similar 93 viraemia profiles, for example, when exposed to same mosquito pools may show very different infectiousness. In such 94 cases, the idea of a variable population of models is more realistic than a single mean-field model [10, 40] . 
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We classify the infected mosquitoes according to the nature of infecting agents as: infected by virus (V (t)), infected by defective particles (D(t)) and infected by both V (t) and D(t). We denote each fraction of the infected mosquitoes with respect to the entire mosquito pool asĨ All categories of the infected mosquitoes are shown in Fig 2. The four columns represent the infection fractions 106 generated for four DENV serotypes. In Fig 2(A), (B) , and (C), we observeĨ V ,Ĩ D andĨ V D , respectively as described in population of models after applying the bang-bang optimal control. The controlled or treated viraemias are lower in peak 116 height and shorter in duration than the untreated viraemias because of the addition of excess DI particles. As a result, 117 the transmission of the viraemia into the mosquito pool are significantly low as shown in Fig 5. In Fig 3, observed as outliers in the population of DENV-1 and DENV-2. If we observe these outlying points carefully, we can 149 make a note that these points appear at the controlled peak values of the viraemias along the x-axis. The corresponding 150 controlledĨ V fractions (see Fig 5(A) ) have similar short-lived sharp peaks between day 0 and day 1 of illness. On this 151 point we want to comment on the dengue transmission by the asymptomatic patients. For a particular value of viraemia, 152 symptom-free dengue patients are significantly more infectious than clinically symptomatic patients [12] . Although, the 153 outlying points in our controlledĨ V fractions are not in the region of significant transmission. On the other hand, with 154 the same reduction in viraemia for DENV-3 and DENV-4,Ĩ V is reduced much more efficiently and they do not posses 155 any such outlying points forĨ V fractions (Fig 6) . 
